Search results
I lost 60 pounds after a minimally invasive experimental procedure
New York Post· 41 minutes agoChristopher McGowan, founder of True You Weight Loss in Cory, North Carolina told Good Morning ...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 23 hours agoTreating America’s obesity epidemic is turning into big business. Two pharmaceutical companies, Eli...
Alabama is among America’s most obese states, survey says
Birmingham News· 8 hours agoAlabama is the seventh most obese state in the U.S., according to U.S. News & World Report. The...
'Surprisingly' high number of adults, even those as young as 20, at risk of heart syndrome
NBC News via Yahoo News· 1 day agoResearchers identified people at high risk using a recently defined syndrome that takes into account...
Amgen soars 16% after it talks up a new weight loss drug that could be injected monthly instead of...
Business Insider via Yahoo Finance· 6 days agoBut demand is so strong that supply has been constrained, and Wall Street analysts believe the total...
Americans need more exercise—and should be able to tap FSA and HSA funds to pay for gyms, studios,...
Fortune via AOL· 2 days agoExercise matters. In the battle against America’s rising tide of overweight and obese youth,...
Woman says she lost 60 pounds after undergoing experimental weight loss procedure
Good Morning America via Yahoo News· 1 day agoThe procedure Nelson underwent is called endoscopic ablation, which the lead author of the clinical...
Patients on hunt for diabetes, obesity and weight-loss drugs - Indianapolis Business Journal
Indianapolis Business Journal· 7 days agoThe phone rings steadily at Phillips Drugs in Richmond these days, with callers asking if the...
Ozempic or Bust
The Atlantic· 1 day agoIn the early spring of 2020, Barb Herrera taped a signed note to a wall of her bedroom in Orlando, Florida, just above her pillow. Barb was nearly 60...
Q1 2024 Rhythm Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoNow I have two slides today, followed by some additional commentary. As listed on (technical difficulty), near term, it is up BBS commercial execution and making IMCIVREE the standard of care ...
